SlideShare a Scribd company logo
PreMaturity
in Newborn
By Ahmad Zulfahmi Sha’ari
Hospital Kemaman
Outlines
• Definition
• Classification
• Causes
• General measures of prematures
• Fluid & Nutrition & Supplements
• Complications
• Follow up cares
Key Facts
• Every year, an estimated 5-18 % or 15 million babies worldwide are born preterm and this
number is rising.
• Preterm birth complications are the leading cause of death among children < 5 years of age,
responsible for approximately 1 million deaths in 2015.
• Three-quarters of these deaths could be prevented with current, cost-effective interventions.
• BASED on the National Obstetric Registry, the incidence of premature births for 14 tertiary
care hospitals in the country in 2012 was at 11.3%.
• Malaysian National Neonatal Registry (MNNR) reported that in 2007, a total of 3,651
infants’ birth weight were less than 1500 grams, or 1.7 % of live births.
DEFINITION
• WHO : Liveborn infants delivered before 37 wks(259 days) from the first
day of the last menstrual period.
• Gestational age: “time elapsed between the first day of the last menstrual
period and the day of delivery.” defined by the American Academy of
Pediatrics (AAP)
Classification
• Gestational age (preterm, late preterm, term, post term),
• Birthweight (extremely low birthweight [ELBW], very low birthweight
[VLBW], low birthweight [LBW], etc.),
• Gestational age and birthweight combined (small for gestational age
[SGA], appropriate for gestational age [AGA], large for gestational age
[LGA]).
The AAP recommends that all newborns be classified by birthweight
and gestational age.
I. Gestational age assessment
• Prenatal assessment :( Maternal history and clinical examination)
• Postnatal gestational age assessment (Rapid assessment, New Ballard
Score, Direct ophthalmoscopy)
• Based on gestational age
Prenatal gestational age assessment
• “Best estimate” of gestational age, since variability as much as 2 weeks can occur.
• 1. Maternal history
• a. Date of last menstrual period. Reliable if dates remembered.
• b. Assisted reproductive technology.
• c. Quickening. (18–20 weeks for a primigravida, 15–17 weeks for a multipara).
Prenatal gestational age assessment
• 2. Clinical examination
• a. Pelvic examination.
• b. Symphysis pubis fundal height. c. Ultrasound examination
• i. First fetal heart tones heard at 8–10 weeks.
• ii. Fetal heart motion/beat at 5.5–6.5 weeks by vaginal ultrasound, and
6.5–7 weeks by fetal ultrasound.
Prenatal gestational age assessment
• iii. First trimester examination
• (a) Gestational sac mean diameter.
• (b) Crown-rump length most reliable measurement of gestational age. It is used to date pregnancy between 6 and
14 weeks. It is accurate within 5 days.
• iv. Second- and third-trimester examination. The most common is the biparietal diameter.
• Other parameters used are head circumference, abdominal circumference, femur length, fetal foot length, and etc.
Postnatal gestational age assessment
• Usually done because prenatal estimates are not always accurate.
• Four approaches have been used: physical criteria alone, neurologic examination alone, physical criteria and
neurologic examination together, and direct ophthalmoscopy.
• Dubowitz originally described a method that included a total of 21 physical and neurologic assessments. The test
was widely used, but because of the time and difficulty in performing the assessment it was shortened and replaced
by the Ballard examination.
• Both the Dubowitz and Ballard examinations were inaccurate at assessing gestational age in preterm neonates
<1500 g and overestimated gestational age.
1. Rapid assessment of gestational age in
the delivery room
Most include some of the following physical characteristics: skin texture, skin color, skin
opacity, edema, lanugo hair, skull hardness, ear form, ear firmness, genitalia, breast size, nipple
formation, and plantar skin creases.
One method for rapid gestational age assessment includes the most useful clinical signs in
differentiating among premature, borderline mature, and full-term infants, which are as
follows (in order of utility): creases in the sole of the foot, size of the breast nodule, nature
of the scalp hair, cartilaginous development of the earlobe, and scrotal rugae and testicular
descent in males.
• Differentiating features
• Sole- have fine wrinkles, creases are not well formed
• • Breast nodule- small or absent
2. New Ballard Score
• The score spans from 10 (correlating with 20 weeks’ gestation) to 50 (correlating with 44 weeks’ gestation).
• It is best performed at <12 hours of age if the infant is <26 weeks’ gestation.
• If the infant is >26 weeks’ gestation, there is no optimal age of examination up to 96 hours.
• Accuracy. It overestimates gestational age by 2–4 days in infants between 32 and 37 weeks’ gestation.
• Criteria. The examination consists of 6 neuromuscular and 6 physical criteria. The neuromuscular criteria
are based on the understanding that passive tone is more useful than active tone in indicating gestational age.
• Procedure. Administered twice by 2 different examiners to ensure objectivity. The examination consists of 2
parts: neuromuscular maturity and physical maturity. The 12 scores are totaled, and the maturity rating is
expressed in weeks of gestation (gestational age), estimated by using the chart provided on the form.
3. Direct ophthalmoscopy
• It is based on the normal embryological process of the gradual disappearance of the
anterior lens capsule vascularity between 27-34 weeks of gestation.
• Before 27 weeks, the cornea is too opaque to allow visualization; after 34 weeks, atrophy of
the vessels of the lens occurs.
• Accurate determination of gestational age at 27–34 weeks only. This method is reliable to
±2 weeks.
• The pupil must be dilated under the supervision of an ophthalmologist, and the assessment
must be performed within 48 hours of birth before the vessels atrophy.
• This method is highly accurate and is not affected by alert states or neurological deficits.
Newborn classification based on gestational age
II. Birthweight classification
• A. Micropreemie. <800 g or 1.8 lb.
• B. Extremely low birthweight (ELBW). <1000 g or 2.2 lb.
• C. Very low birthweight (VLBW). <1500 g or 3.3 lb.
• D. Low birthweight (LBW). <2500 g or 5.5 lb.
• E. Normal birthweight (NBW). 2500 g (5.5 lb) to 4000 g (8.8 lb).
• F. High birthweight (HBW). 4000 g (8.8 lb) to 4500 g (9.9 lb).
• G. Very high birthweight (VHBW). >4500 g (9.9 lb).
III. Classification by birthweight and
gestational age combined
• Plotting these against standardized intrauterine growth charts.
• This allows categorization as SGA, AGA, or LGA.
• These refer to the size of the infant at birth and not fetal growth.
• A. How to decide if the infant is SGA, AGA, or LGA? Plot gestational
assessment
• against weight, length, and head circumference on one of the intrauterine growth
• charts to determine whether the infant is small, appropriate, or large for gestational
age.
• 1. Appropriate for gestational age (AGA). Between the 10th and 90th
percentiles for the infant’s gestational age.
• 2. Small for gestational age (SGA). Defined as a birthweight 2 standard
deviations below the mean weight for gestational age OR below the 10th
percentile
• 3. Large for gestational age (LGA). Defined as a birthweight 2 standard
deviations above the mean weight for gestational age OR above the 90th
percentile.
Causes
• Multifactorial and involves complex interaction between fetal, placental, uterine and
maternal factors
• Fetal
• • Fetal distress • IUGR • Multiple gestation • Erythroblastosis • Non immune
hydrops
• Placental
• • Placental dysfunction • Placenta previa • Abruptio placentae • Uterine • trauma •
Bicornuate uterus • Incompetent cervix ( premature dilatation)/surgery
• Maternal
• • women younger than 16 and older than 35 • Maternal activity • Prior poor
birth outcome • Inadvertent early delivery • Preeclampsia • Chronic medical
illness • Infection • Drug abuse
• • chorioamnionitis • PROM • Polyhydramnios • Iatrogenic/ trauma
PRENATAL CONSIDERATIONS
• • Should be delivered in a facility with high risk obstetrical service and level 3
NICU
• • Prenatal administration of glucocorticoids to the mother even if there is no
time for full course
• ETHICS- counselling should include discussions regarding survival rate and
both short and long term complications
Management Before and During Labour
• Prewarmed incubator and appropriate equipment for neonatal intensive
care should always be kept ready in the labour room or operating theatre.
Adequate Resuscitation
• Thermoregulation. A polyethylene wrap or bag used immediately after birth
prevents heat loss at delivery in very preterm infants.
• Respiratory support, availability of pulse oximetry and blended O2 for
resuscitation and low saturation protocol.
• If the infant is breathing spontaneously and heart rate >100, (CPAP) of 4–6 cm
H2O should be initiated to prevent atelectasis.
• Transport. As soon as possible, the infant should be transported to the NICU.
• In a prewarmed portabe incubator equipped with blended O2 and CPAP availability.
• If not the baby must be wiped dry and wrapped in dry linen before transfer.
Admission Routine
• Ensure thermoneutral temperature for infant. An incubator or radiant warmer is necessary.
• Ventilation in NICU is often necessary if ventilated during transfer. However, some infants take longer to adapt to
extrauterine life and may not require ventilation especially those with no risk factors and given a full course of
antenatal steroids.
• For the larger preterm infants above 1250 grams, review the required ventilation to maintain a satisfactory blood gas
and consider extubation if the ventilator requirements are low, patient has good tone and good spontaneous
respiration.
Admission Routine
• Maintain SaO₂ between 89-92% for ELBW; 90-94% for the larger preterm
• Head circumference (OFC), length measurements, bathing can be omitted.
• Quickly and accurately examine and weigh the infant.
• Assess the gestational age with Dubowitz or Ballard score when stable.
• Monitor temp, HR, RR, BP and SaO₂.
Immediate Care for Symptomatic infants
• • Investigations are necessary as indicated : ABG, DXT, FBC, Blood culture, CXR (if respiratory signs and symptoms
are present)
• • Start on 10% dextrose drip.
• • Correct hypotension (keep mean arterial pressure (MAP) > gestational age (GA) in wks). Ensure hyperventilation is
not present (a cause of hypotension). If the baby has good tone and is active, observe first as the BP may rise after
first few hours of life towards a MAP approximating GA in weeks.
• • Correct hypovolaemia: Give 10 ml/kg of Normal Saline over 20-30 mins, or packed cells if anaemic. Avoid repeat
fluid boluses unless there is volume loss.
• • Start inotrope infusion if hypotension persists after volume correction.
• • Start antibiotics after taking cultures e.g. Penicillin and Gentamycin
• • Start IV Aminophylline or caffeine in premature infants <32-34 weeks.
• • Maintain SaO₂ at 89-92% and PaO₂ at 50 –70 mmHg.
General Measures for Premature infants
• Monitor vitals signs (colour, temperature, apex beat, respiratory rate). Look for signs of
respiratory distress (cyanosis, grunting, tachypnoea, nasal flaring, chest recessions, apnoea).
In VLBL and ill infants pulse oximetry and blood pressure monitoring are necessary.
• Check Blood Sugar .
• Keep warm in incubator at thermoneutral temperature for age and birth weight. ELBW
should preferably have humidified environment at least for the first 3 days.
• Ensure adequate nutrition.
• Provide parental counselling and allow free parental access.
• Infection control: observe strict hand washing practices.
Temperature and humidity control.
• Has large skin surface area and minimal energy reserves, a constant neutral thermal
environment (environmental temperature that minimizes heat loss without increasing O2
consumption or incurring metabolic stress) is essential.
• To maintain minimal evaporative heat loss, it is best if the environmental humidity is 80.
• Warm humidification within the incubator is recommended.
• Minimize nosocomial infection in humidified environments.
Temperature and Humidity
They have poor mechanisms for regulation of temperature and depend on environmental support.
• 1. Maintain axillary skin temperature of 36.0–36.5°C.
• 2. Record skin temperature.
• 3. Record the incubator humidity.
• 4. Weigh low birthweight infants at least once daily for management of fluids and electrolytes.
• 5. Other heat-conserving practices. (knit hats, fetal positioning, and air boost curtains on
incubators.)
• 6. Accessory items for infant care must be prewarmed. To avoid heat loss by conduction.
Infusion fluid volumes
Preterm low birthweight infants (>1500 g) require 60–80 mL/kg/d.
Preterm very low birthweight infants (1000–1500 g) require 80–100 mL/kg/d.
Preterm extremely low birthweight infants (<1000 g) require a range of fluid
volumes from 50–80 mL/kg/d if cared for in doublewalled humidified (80%)
incubators.
If cared for under a radiant warmer or in incubators without humidity, fluid
requirements may be 100–200 mL/kg/d (see Table 12–1 for breakdown into
100-g birthweight increments).
Nutrition
• Breast milk is the milk of choice. All mothers should be encouraged to give breast milk to their
newborn babies.
• Infant Formula Infant formula should only be given if there is no supply of EBM.
• Preterm formula : for babies born < 32 weeks or < 1500 grams
• It is recommended to add HMF to EBM as it will give extra calories, vitamins, calcium and phosphate.
• Preterm infants : 120 – 140 kcal/kg/day
• Babies who have had a more eventful course need up to 180kcal/kg/day to have adequate weight gain.
• TPN can be start within the first 24 hours OL in the smaller preterm infants BW <1250 grams or as
indicated.
Minimal enteral feeding (MEF)
• Recommended in very preterm infants
• The principle is to commence very low volume enteral feeds on day 1 - 3 of
life (i.e. 5 - 25 mls/kg/day) for both EBM and formula milk.
• MEF enhances gut DNA synthesis hence promotes gastrointestinal growth.
• This approach allows earlier establishment of full enteral feeds and shorter
hospital stays, without any concomitant increase in NEC.
Vitamins & Iron
• At birth: IM Vitamin K (0.5 mg for BW<2.5 kg; 1 mg for BW ≥ 2.5 kg)
• MVT can be given after day 14 of life when on feeding of 150 ml/s kg/day.(once on full feeding)
• Supplements at 0.5 mls daily to be continued for 3-4 months post discharge.
• Premature infants have reduced intra uterine iron accumulation and can become rapidly depleted of iron
when active erythropoiesis resumes. Babies of BW< 2000g should receive iron supplements.
• Iron is given at a dose of 3 mg/kg elemental iron per day.
• Ferric Ammonium Citrate (400mg/5mls) contains 86 mg/5 mls of elemental iron.
• Start on day 42 (6 week), continue until 3-4 months post discharge or until review.
• Babies who have received multiple blood transfusions may not require as much iron supplementation.
Immunisation
• Hep B vaccine at birth if infant stable and BW is >1.8 kg. Otherwise give
before discharge.
• Ensure BCG vaccine is given on discharge.
• For long stayers other immunisation should generally follow the schedule
according to chronological rather than corrected age.
• Defer immunisation in the presence of acute illnesses.
Skin care
• Zinc-based tape can be used.
• Alternatives to tape include the use of a hydrogel adhesive, which removes easily with water.
Products also include electrodes, temperature probe covers, and masks.
• Skin care must focus on maintaining skin integrity and minimizing exposure to topical agents.
• Transparent adhesive dressings can be used over areas of bone prominence, such as the knees or
elbows, to prevent skin friction breakdown and under adhesive monitoring devices that are frequently
moved.
• Use of humidity helps maintain skin integrity until skin is mature (2–3 weeks).
Complications
Generally
Early
• Hypothermia – large surface area, thin skin, less fat (less brown fat, more
glycogen).
• Hypoglycemia
• Infection
RESPIRATORY ISSUES
• Poor development of respiratory muscles- CPAP or ventilator support
• a) Perinatal depression-special care air-oxygen mixtures, oximetry
monitoring, prevent heat loss
• b) RDS- due to surfactant deficiency
• • APNEA • Due to developmental immaturity of central respiratory drive
RDS
• ~91% at 23–25 weeks’ gestation, 88% at 26–27 weeks’, gestation, 74 % at 28–29
weeks’ gestation, and 52% at 30–31 weeks’ gestation.
• Sx: Tachypnoea, labored breathing, recessions, nasal flaring, expiratory grunting,
+-cyanosis
• CXR: Uniform reticulogranular pattern (ground glass appearance) with/out low
lung volume and peripheral air bronchogram within the first 24 hours of life.
• Mx: Antenatal corticosteroids, tocolytic agent, surfactant replacement, Respiratory
support; ETT ventilation, CPAP, SIMV, SEDATION Fluid & nutritional support,
Antibx
Surfactant
synthesis begins at 24–28 weeks’ gestation
• The survival from RDS is at >90%. RDS accounts for <6%of all neonatal deaths.
• Some literature supports early administration of surfactant during the first 4 hours
of life to decrease chronic lung disease.
• Recent research supports early CPAP in the delivery room over prophylactic
surfactant.
• Administration criteria for surfactant include absence of antenatal steroids,
increased oxygen demand >30%, and a radiograph consistent with surfactant
deficiency.
Apnea of prematurity
• Pause of breathing > 20secs with brady or desaturation, HR drop 30bpm
from baseline
• Cause: Physiologic immaturity of respiratory centre, lack of pharyngeal
muscle tone and collapsed upper airway -usually present after 1–2 days of
life,
• Mx: Supportive O2, relieve obstruction (CPAP), aminophylline/caffeine
citrate as resp. stimulant, mechanical ventilation.
NEUROLOGIC
• • Perinatal depression
• • ICH- from fragile involuting vessels –Cranium USG at 5-7 days
• Neurodevelopmental delay, growth failure, cerebral palsy, mental retardation,
epilepsy, blindness and deafness
IVH and PVL
• IVH (intraventricular hemorrhage) - fragile blood vessels in germinal
matrix above caudate nucleus - occurs in < 32wks (within 5 days after birth)
• Sx: pallor, shock, hypotonia, apnoea, seizure, hydrocephalus
• PVL (Periventricular leucomalacia) - necrosis of white matter at dorsal
and lateral
• Complications: spastic diplegia, cognitive and intelectual deficit, visual deficit,
seizure disorder
CARDIOVASCULAR
• A) hypotension• hypovolemia • cardiac dysfunction • sepsis induced
vasodilation •
• B) PDA- between 24-48 hrs of birth
Patent Ductus Arteriosus
• Incidence of persistent PDA is inversely proportional to gestational age.
• SSx include: Wide pulse pressure/ bounding pulses • Systolic or continuous murmur
• Tachycardia • Lifting of xiphisternum with heart beat • Hyperactive precordium •
Apnoea • Increase in ventilatory requirements
• An echocardiogram is recommended to rule out other structural heart defects and
confirmation of PDA when concerned.
• Overhydration must be avoided.
• Up to 30% of PDAs spontaneously close.
PDA
• Currently it is unclear whether a conservative, pharmacologic or surgical
approach is advantageous.
• If the decision is made to treat a hemodynamically significant PDA,
indomethacin or ibuprofen is generally accepted.
• Renal and GI adverse effects are less common with administration of
ibuprofen or with slower infusion rates of indomethacin.
PDA
• IV or oral Indomethacin 0.2mg/kg/day daily dose for 3 days or
• IV or oral Ibuprofen 10mg/kg first dose, 5mg/kg second and third doses,
administered by syringe pump over 15 minutes at 24 hour intervals.
Surgical ligation
• Persistence of a symptomatic PDA and failed 2 courses of Indomethacin
• If medical treatment fails or contraindicated
In older preterm infant who is asymptomatic, i.e. only cardiac murmur present in an otherwise
well baby – no treatment required. Most PDA in this group will close spontaneously.
HEMATOLOGIC
• • A) anaemia- exaggeration of normal physiologic anaemia
• TRANSFUSION- low RBC volume, low hematocrit <40%
• • B) Hyperbilirubinemia
• keep SBR <10 mg/dl
• • exchange transfusion if > 12mg/dl
GI
• Increased risk of NEC, paralytic ileus
• Feeding intolerance
• • formula feeding is an additional risk factor
• • breast milk- protective • gradual increments in feeds
• • Renal- immature kidneys-low GFR
NEC
• Ischemic and inflammatory necrosis of the bowel primarily affecting premature neonates after the initiation
of enteral feeding.
• Incidence 6–10% in infants weighing <1500 g.
• Usually occurs within 1st week of life/ between 14 and 20 days of age or 30–32 weeks’
• Sx: Feeding intolerance, abdominal distension, blood in stool, vomit milkcurd /greenish bile, shiny skin
abdomen, absent BS
• AXR: distended loops of bowel, Pneumatosis, pneumoperitoneum
• Mx: keep NBM, start parenteral feeding (TPN/OGT), antibx for 10-14days regimen should cover pathogens
that can cause late-onset sepsis + anaerobic coverage if bowel necrosis or perforation.
• Complications: bowel perforation, strictures, malabsorption, parenteral nutrition–associated liver disease
Prognosis in Prematurity
• Mortality and morbidity are inversely related to gestation and birth weight.
• Complications include retinopathy of prematurity, chronic lung disease,
neurodevelopmental delay, growth failure, cerebral palsy, mental retardation,
epilepsy, blindness and deafness
FOLLOW UP CARE
• • Respiratory syncytial virus –most important cause of respiratory infection in premature infants
Good hand hygiene, avoid passive cigarette smoking exposure • Influenza vaccine- when older
than 6 months
• • Immunizations-same schedule as term infants with exception of hepatitis B • Medically
stable,thriving infants- hep B as early as 30 days of age regardless of gestational age or bw
• • Anaemia- supplemental iron(2-3mg/kg) for first 12-15 months of life • Multivitamin drops- 2
weeks of age
• • Rickets- higher risk infants- long term parenteral nutrition, frusemide and fat malabsorption •
All breast fed infants- 400 IU of vit D along with calcium 200mg/kg at time of discharge
• • Metabolic screening at 3-4 weeks of age
Screening
Cranial Ultrasound for premature infants ≤ 32 weeks is recommended at:
• • Within first week of life to look for intraventricular haemorrhage (IVH).
• • Around day 28 to look for periventricular leucomalacia (PVL).
• • As clinically indicated.
Screening for Retinopathy of Prematurity (ROP) at 4-6 weeks of age is recommended for
• All infants ≤ 32 weeks gestation at birth or birth weight <1500 g.
• All preterms < 36 weeks who received oxygen therapy depending on individual risk as assessed by the
clinician.
• The infants are discharged once they are well, showing good weight gain, established oral feeding
and gestational age of at least 35 weeks.
When is infant ready for discharge??
Once they are well, showing good weight gain, established oral feeding and gestational age of at least 35 weeks.
• • A sustained pattern of weight gain(15-25 gm) • Competent feeding by breast or pallada
without cardiorespiratory compromise • Physiologically mature and stable cardiorespiratory
function
• • An apnea free period(5-7days) • Nutritional risks assessed and therapy dietary modification
• • Hearing evaluation • Fundoscopic examination • Neurodevelopmental and neurobehavioral
status assessed and explained to parents • Review of hospital course completed.
• • Family and parents: • Determine family’s caregiving and psychosocial readiness • Pre discharge
education-safe sleep practices and SIDS prevention.
• • Parents should be able to- independently and confidently care for their infant; • provide
medications, nutritional supplements and any special medical care; • recognize signs and
symptoms of illness and respond appropriately • understand the importance of infection control
measures and a smoke-free environment.
Thank You
November 17th is World Prematurity Day
On this day, efforts are made to increase awareness of the health risks
associated with preterm birth and how to reduce them.
References
• PAEDIATRIC PROTOCOLS For Malaysian Hospitals (3rd Edition) by Hussain Imam Hj Muhammad
Ismail/ Ng Hoong Phak/Terrence Thomas
• NEONATOLOGY Management, Procedures, On-Call Problems, Diseases, and Drugs (7th Edition) by
LACY GOMELLA, MD/M. DOUGLAS CUNNINGHAM, MD/FABIEN G. EYAL, MD
• https://emedicine.medscape.com/article/prematurity/ updated Oct 13, 2017 by Susan A Furdon, RNC, NNP-BC,
MS Neonatal Clinical Nurse Specialist/Nurse Practitioner, Department of Pediatrics, Albany Medical Center

More Related Content

What's hot

Post term pregnancy
Post term pregnancyPost term pregnancy
Post term pregnancydrmcbansal
 
Infant of diabetic mother
Infant of diabetic motherInfant of diabetic mother
Infant of diabetic mother
Dr Praman Kushwah
 
antepartum haemorrhage by shubham kumbare
antepartum haemorrhage by shubham kumbareantepartum haemorrhage by shubham kumbare
antepartum haemorrhage by shubham kumbare
Shubham Kayande
 
Hypothermia in newborn
Hypothermia in newbornHypothermia in newborn
Hypothermia in newborn
dr jyoti prajapati
 
prematurity
prematurityprematurity
prematurityssn zhd
 
Lactation failure
Lactation failureLactation failure
Lactation failure
Sonali Singh
 
Polycythemia
PolycythemiaPolycythemia
Polycythemia
vijay dihora
 
Neonatal asphyxia
Neonatal asphyxiaNeonatal asphyxia
Neonatal asphyxia
Nosrullah Ayodele
 
Intrauterine Growth Restriction (IUGR) / Small For gestational Age
Intrauterine Growth Restriction (IUGR) / Small For gestational Age Intrauterine Growth Restriction (IUGR) / Small For gestational Age
Intrauterine Growth Restriction (IUGR) / Small For gestational Age
POOJA KUMAR
 
Post term pregnancy
Post term pregnancyPost term pregnancy
Post term pregnancy
Vihari Rajaguru
 
Delayed cord clamping
Delayed cord clampingDelayed cord clamping
Delayed cord clamping
Adhi Arya
 
Aph Antepartum hemorrhage
Aph Antepartum hemorrhageAph Antepartum hemorrhage
Aph Antepartum hemorrhage
HuzaifaMD
 
Presentation on neonatal hypocalcemia hypoglycemia hypomagnesaemia
Presentation on neonatal hypocalcemia hypoglycemia hypomagnesaemiaPresentation on neonatal hypocalcemia hypoglycemia hypomagnesaemia
Presentation on neonatal hypocalcemia hypoglycemia hypomagnesaemia
Gnana Jyothi
 
Necrotising Enterocolitis(NEC)
Necrotising Enterocolitis(NEC)Necrotising Enterocolitis(NEC)
Necrotising Enterocolitis(NEC)
Sid Kaithakkoden
 
Infant of diabetic mother
Infant of diabetic motherInfant of diabetic mother
Infant of diabetic mother
Sayed Ahmed
 
Macrosomia and iugr with case study for undergraduare
Macrosomia and iugr with case study for undergraduareMacrosomia and iugr with case study for undergraduare
Macrosomia and iugr with case study for undergraduare
Faculty of Medicine,Zagazig University,EGYPT
 
Asphyxia of the newborn. Birth trauma
Asphyxia of the newborn. Birth traumaAsphyxia of the newborn. Birth trauma
Asphyxia of the newborn. Birth trauma
Eneutron
 
PROM
PROMPROM

What's hot (20)

Post term pregnancy
Post term pregnancyPost term pregnancy
Post term pregnancy
 
Infant of diabetic mother
Infant of diabetic motherInfant of diabetic mother
Infant of diabetic mother
 
antepartum haemorrhage by shubham kumbare
antepartum haemorrhage by shubham kumbareantepartum haemorrhage by shubham kumbare
antepartum haemorrhage by shubham kumbare
 
Hypothermia in newborn
Hypothermia in newbornHypothermia in newborn
Hypothermia in newborn
 
prematurity
prematurityprematurity
prematurity
 
Lactation failure
Lactation failureLactation failure
Lactation failure
 
Polycythemia
PolycythemiaPolycythemia
Polycythemia
 
Prematurity
PrematurityPrematurity
Prematurity
 
Neonatal asphyxia
Neonatal asphyxiaNeonatal asphyxia
Neonatal asphyxia
 
Intrauterine Growth Restriction (IUGR) / Small For gestational Age
Intrauterine Growth Restriction (IUGR) / Small For gestational Age Intrauterine Growth Restriction (IUGR) / Small For gestational Age
Intrauterine Growth Restriction (IUGR) / Small For gestational Age
 
Post term pregnancy
Post term pregnancyPost term pregnancy
Post term pregnancy
 
Delayed cord clamping
Delayed cord clampingDelayed cord clamping
Delayed cord clamping
 
Aph Antepartum hemorrhage
Aph Antepartum hemorrhageAph Antepartum hemorrhage
Aph Antepartum hemorrhage
 
Presentation on neonatal hypocalcemia hypoglycemia hypomagnesaemia
Presentation on neonatal hypocalcemia hypoglycemia hypomagnesaemiaPresentation on neonatal hypocalcemia hypoglycemia hypomagnesaemia
Presentation on neonatal hypocalcemia hypoglycemia hypomagnesaemia
 
Necrotising Enterocolitis(NEC)
Necrotising Enterocolitis(NEC)Necrotising Enterocolitis(NEC)
Necrotising Enterocolitis(NEC)
 
Neonatal convulsion
Neonatal convulsionNeonatal convulsion
Neonatal convulsion
 
Infant of diabetic mother
Infant of diabetic motherInfant of diabetic mother
Infant of diabetic mother
 
Macrosomia and iugr with case study for undergraduare
Macrosomia and iugr with case study for undergraduareMacrosomia and iugr with case study for undergraduare
Macrosomia and iugr with case study for undergraduare
 
Asphyxia of the newborn. Birth trauma
Asphyxia of the newborn. Birth traumaAsphyxia of the newborn. Birth trauma
Asphyxia of the newborn. Birth trauma
 
PROM
PROMPROM
PROM
 

Similar to Pre maturity of newborn

Unit III, Nursing care of a neonate PART 1.pptx
Unit III, Nursing  care of a neonate PART 1.pptxUnit III, Nursing  care of a neonate PART 1.pptx
Unit III, Nursing care of a neonate PART 1.pptx
ranigs2
 
Essential newborn care
Essential newborn care Essential newborn care
Essential newborn care
Santhosh S.U.
 
CARE OF HIGH RISK NEWBORN.pptx
CARE OF HIGH RISK NEWBORN.pptxCARE OF HIGH RISK NEWBORN.pptx
CARE OF HIGH RISK NEWBORN.pptx
Julie Kisku
 
ANC.pptx
ANC.pptxANC.pptx
ANC.pptx
GyetHenryInno
 
post maturity .prolonged pregnancy.pptx
post maturity .prolonged pregnancy.pptxpost maturity .prolonged pregnancy.pptx
post maturity .prolonged pregnancy.pptx
CaiusMbao
 
Essential new born care latest
Essential new born care latestEssential new born care latest
Essential new born care latest
sumi57
 
Unit IV new born.pptx
Unit IV new born.pptxUnit IV new born.pptx
Unit IV new born.pptx
DelphyVarghese
 
ART OF NEONATAL EXAMINATION & DANGER SIGNS.ppt
ART OF NEONATAL EXAMINATION & DANGER  SIGNS.pptART OF NEONATAL EXAMINATION & DANGER  SIGNS.ppt
ART OF NEONATAL EXAMINATION & DANGER SIGNS.ppt
madhurathore16
 
NEWBORN.pptx
NEWBORN.pptxNEWBORN.pptx
NEWBORN.pptx
Rajani17
 
Approach to Intrauterine growth restriction
Approach to Intrauterine growth restrictionApproach to Intrauterine growth restriction
Approach to Intrauterine growth restriction
Dr. Habibur Rahim
 
Care of newborn
Care of newbornCare of newborn
Care of newborn
Aditi Ujjawal
 
How to determine gestational age of pregnancy
How to determine gestational age of pregnancy How to determine gestational age of pregnancy
How to determine gestational age of pregnancy
Sasha Bondi
 
Follow up of high-risk newborn-1
Follow up of high-risk newborn-1Follow up of high-risk newborn-1
Follow up of high-risk newborn-1
ankur priyadarshi
 
Antenatal care.pptx
Antenatal care.pptxAntenatal care.pptx
Antenatal care.pptx
Saima Mustafa
 
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptx
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptxNursing management of Preterm, Term, Post-term and IUGR Baby.pptx
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptx
SWARAJSUMAN
 
Fgr report
Fgr reportFgr report
Fgr report
maricar chua
 
Determination of gestational age revised copy
Determination of gestational age  revised   copyDetermination of gestational age  revised   copy
Determination of gestational age revised copy
AWOYEMI FRANCIS Oluwaseyi
 
IUGR (intra uterine growth restrictions )
IUGR (intra uterine growth restrictions )IUGR (intra uterine growth restrictions )
IUGR (intra uterine growth restrictions )
Sujata Bhardwaj
 
Essential newborn care
Essential newborn careEssential newborn care
Essential newborn care
AshaSebastian1
 

Similar to Pre maturity of newborn (20)

Unit III, Nursing care of a neonate PART 1.pptx
Unit III, Nursing  care of a neonate PART 1.pptxUnit III, Nursing  care of a neonate PART 1.pptx
Unit III, Nursing care of a neonate PART 1.pptx
 
Essential newborn care
Essential newborn care Essential newborn care
Essential newborn care
 
CARE OF HIGH RISK NEWBORN.pptx
CARE OF HIGH RISK NEWBORN.pptxCARE OF HIGH RISK NEWBORN.pptx
CARE OF HIGH RISK NEWBORN.pptx
 
ANC.pptx
ANC.pptxANC.pptx
ANC.pptx
 
post maturity .prolonged pregnancy.pptx
post maturity .prolonged pregnancy.pptxpost maturity .prolonged pregnancy.pptx
post maturity .prolonged pregnancy.pptx
 
Essential new born care latest
Essential new born care latestEssential new born care latest
Essential new born care latest
 
Unit IV new born.pptx
Unit IV new born.pptxUnit IV new born.pptx
Unit IV new born.pptx
 
Preterm labor
Preterm laborPreterm labor
Preterm labor
 
ART OF NEONATAL EXAMINATION & DANGER SIGNS.ppt
ART OF NEONATAL EXAMINATION & DANGER  SIGNS.pptART OF NEONATAL EXAMINATION & DANGER  SIGNS.ppt
ART OF NEONATAL EXAMINATION & DANGER SIGNS.ppt
 
NEWBORN.pptx
NEWBORN.pptxNEWBORN.pptx
NEWBORN.pptx
 
Approach to Intrauterine growth restriction
Approach to Intrauterine growth restrictionApproach to Intrauterine growth restriction
Approach to Intrauterine growth restriction
 
Care of newborn
Care of newbornCare of newborn
Care of newborn
 
How to determine gestational age of pregnancy
How to determine gestational age of pregnancy How to determine gestational age of pregnancy
How to determine gestational age of pregnancy
 
Follow up of high-risk newborn-1
Follow up of high-risk newborn-1Follow up of high-risk newborn-1
Follow up of high-risk newborn-1
 
Antenatal care.pptx
Antenatal care.pptxAntenatal care.pptx
Antenatal care.pptx
 
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptx
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptxNursing management of Preterm, Term, Post-term and IUGR Baby.pptx
Nursing management of Preterm, Term, Post-term and IUGR Baby.pptx
 
Fgr report
Fgr reportFgr report
Fgr report
 
Determination of gestational age revised copy
Determination of gestational age  revised   copyDetermination of gestational age  revised   copy
Determination of gestational age revised copy
 
IUGR (intra uterine growth restrictions )
IUGR (intra uterine growth restrictions )IUGR (intra uterine growth restrictions )
IUGR (intra uterine growth restrictions )
 
Essential newborn care
Essential newborn careEssential newborn care
Essential newborn care
 

More from AZu SA

The RED EYE
The RED EYEThe RED EYE
The RED EYE
AZu SA
 
Ptosis
PtosisPtosis
Ptosis
AZu SA
 
Basic approach on hvf
Basic approach on hvfBasic approach on hvf
Basic approach on hvf
AZu SA
 
Approaching the eyes
Approaching the eyesApproaching the eyes
Approaching the eyes
AZu SA
 
Septic arthritis
Septic arthritisSeptic arthritis
Septic arthritis
AZu SA
 
Nephrotic syndrome
Nephrotic syndrome Nephrotic syndrome
Nephrotic syndrome
AZu SA
 
Approach to jaundice
Approach to jaundice Approach to jaundice
Approach to jaundice
AZu SA
 

More from AZu SA (7)

The RED EYE
The RED EYEThe RED EYE
The RED EYE
 
Ptosis
PtosisPtosis
Ptosis
 
Basic approach on hvf
Basic approach on hvfBasic approach on hvf
Basic approach on hvf
 
Approaching the eyes
Approaching the eyesApproaching the eyes
Approaching the eyes
 
Septic arthritis
Septic arthritisSeptic arthritis
Septic arthritis
 
Nephrotic syndrome
Nephrotic syndrome Nephrotic syndrome
Nephrotic syndrome
 
Approach to jaundice
Approach to jaundice Approach to jaundice
Approach to jaundice
 

Recently uploaded

role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
sonaliswain16
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SELF-EXPLANATORY
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
muralinath2
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
AADYARAJPANDEY1
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
silvermistyshot
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
Sérgio Sacani
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
IqrimaNabilatulhusni
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 

Recently uploaded (20)

role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 

Pre maturity of newborn

  • 1. PreMaturity in Newborn By Ahmad Zulfahmi Sha’ari Hospital Kemaman
  • 2. Outlines • Definition • Classification • Causes • General measures of prematures • Fluid & Nutrition & Supplements • Complications • Follow up cares
  • 3. Key Facts • Every year, an estimated 5-18 % or 15 million babies worldwide are born preterm and this number is rising. • Preterm birth complications are the leading cause of death among children < 5 years of age, responsible for approximately 1 million deaths in 2015. • Three-quarters of these deaths could be prevented with current, cost-effective interventions. • BASED on the National Obstetric Registry, the incidence of premature births for 14 tertiary care hospitals in the country in 2012 was at 11.3%. • Malaysian National Neonatal Registry (MNNR) reported that in 2007, a total of 3,651 infants’ birth weight were less than 1500 grams, or 1.7 % of live births.
  • 4. DEFINITION • WHO : Liveborn infants delivered before 37 wks(259 days) from the first day of the last menstrual period. • Gestational age: “time elapsed between the first day of the last menstrual period and the day of delivery.” defined by the American Academy of Pediatrics (AAP)
  • 5. Classification • Gestational age (preterm, late preterm, term, post term), • Birthweight (extremely low birthweight [ELBW], very low birthweight [VLBW], low birthweight [LBW], etc.), • Gestational age and birthweight combined (small for gestational age [SGA], appropriate for gestational age [AGA], large for gestational age [LGA]). The AAP recommends that all newborns be classified by birthweight and gestational age.
  • 6. I. Gestational age assessment • Prenatal assessment :( Maternal history and clinical examination) • Postnatal gestational age assessment (Rapid assessment, New Ballard Score, Direct ophthalmoscopy) • Based on gestational age
  • 7. Prenatal gestational age assessment • “Best estimate” of gestational age, since variability as much as 2 weeks can occur. • 1. Maternal history • a. Date of last menstrual period. Reliable if dates remembered. • b. Assisted reproductive technology. • c. Quickening. (18–20 weeks for a primigravida, 15–17 weeks for a multipara).
  • 8. Prenatal gestational age assessment • 2. Clinical examination • a. Pelvic examination. • b. Symphysis pubis fundal height. c. Ultrasound examination • i. First fetal heart tones heard at 8–10 weeks. • ii. Fetal heart motion/beat at 5.5–6.5 weeks by vaginal ultrasound, and 6.5–7 weeks by fetal ultrasound.
  • 9. Prenatal gestational age assessment • iii. First trimester examination • (a) Gestational sac mean diameter. • (b) Crown-rump length most reliable measurement of gestational age. It is used to date pregnancy between 6 and 14 weeks. It is accurate within 5 days. • iv. Second- and third-trimester examination. The most common is the biparietal diameter. • Other parameters used are head circumference, abdominal circumference, femur length, fetal foot length, and etc.
  • 10. Postnatal gestational age assessment • Usually done because prenatal estimates are not always accurate. • Four approaches have been used: physical criteria alone, neurologic examination alone, physical criteria and neurologic examination together, and direct ophthalmoscopy. • Dubowitz originally described a method that included a total of 21 physical and neurologic assessments. The test was widely used, but because of the time and difficulty in performing the assessment it was shortened and replaced by the Ballard examination. • Both the Dubowitz and Ballard examinations were inaccurate at assessing gestational age in preterm neonates <1500 g and overestimated gestational age.
  • 11. 1. Rapid assessment of gestational age in the delivery room Most include some of the following physical characteristics: skin texture, skin color, skin opacity, edema, lanugo hair, skull hardness, ear form, ear firmness, genitalia, breast size, nipple formation, and plantar skin creases. One method for rapid gestational age assessment includes the most useful clinical signs in differentiating among premature, borderline mature, and full-term infants, which are as follows (in order of utility): creases in the sole of the foot, size of the breast nodule, nature of the scalp hair, cartilaginous development of the earlobe, and scrotal rugae and testicular descent in males.
  • 12.
  • 13. • Differentiating features • Sole- have fine wrinkles, creases are not well formed • • Breast nodule- small or absent
  • 14.
  • 15.
  • 16.
  • 17. 2. New Ballard Score • The score spans from 10 (correlating with 20 weeks’ gestation) to 50 (correlating with 44 weeks’ gestation). • It is best performed at <12 hours of age if the infant is <26 weeks’ gestation. • If the infant is >26 weeks’ gestation, there is no optimal age of examination up to 96 hours. • Accuracy. It overestimates gestational age by 2–4 days in infants between 32 and 37 weeks’ gestation. • Criteria. The examination consists of 6 neuromuscular and 6 physical criteria. The neuromuscular criteria are based on the understanding that passive tone is more useful than active tone in indicating gestational age. • Procedure. Administered twice by 2 different examiners to ensure objectivity. The examination consists of 2 parts: neuromuscular maturity and physical maturity. The 12 scores are totaled, and the maturity rating is expressed in weeks of gestation (gestational age), estimated by using the chart provided on the form.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26. 3. Direct ophthalmoscopy • It is based on the normal embryological process of the gradual disappearance of the anterior lens capsule vascularity between 27-34 weeks of gestation. • Before 27 weeks, the cornea is too opaque to allow visualization; after 34 weeks, atrophy of the vessels of the lens occurs. • Accurate determination of gestational age at 27–34 weeks only. This method is reliable to ±2 weeks. • The pupil must be dilated under the supervision of an ophthalmologist, and the assessment must be performed within 48 hours of birth before the vessels atrophy. • This method is highly accurate and is not affected by alert states or neurological deficits.
  • 27.
  • 28. Newborn classification based on gestational age
  • 29. II. Birthweight classification • A. Micropreemie. <800 g or 1.8 lb. • B. Extremely low birthweight (ELBW). <1000 g or 2.2 lb. • C. Very low birthweight (VLBW). <1500 g or 3.3 lb. • D. Low birthweight (LBW). <2500 g or 5.5 lb. • E. Normal birthweight (NBW). 2500 g (5.5 lb) to 4000 g (8.8 lb). • F. High birthweight (HBW). 4000 g (8.8 lb) to 4500 g (9.9 lb). • G. Very high birthweight (VHBW). >4500 g (9.9 lb).
  • 30. III. Classification by birthweight and gestational age combined • Plotting these against standardized intrauterine growth charts. • This allows categorization as SGA, AGA, or LGA. • These refer to the size of the infant at birth and not fetal growth. • A. How to decide if the infant is SGA, AGA, or LGA? Plot gestational assessment • against weight, length, and head circumference on one of the intrauterine growth • charts to determine whether the infant is small, appropriate, or large for gestational age.
  • 31. • 1. Appropriate for gestational age (AGA). Between the 10th and 90th percentiles for the infant’s gestational age. • 2. Small for gestational age (SGA). Defined as a birthweight 2 standard deviations below the mean weight for gestational age OR below the 10th percentile • 3. Large for gestational age (LGA). Defined as a birthweight 2 standard deviations above the mean weight for gestational age OR above the 90th percentile.
  • 32. Causes • Multifactorial and involves complex interaction between fetal, placental, uterine and maternal factors • Fetal • • Fetal distress • IUGR • Multiple gestation • Erythroblastosis • Non immune hydrops • Placental • • Placental dysfunction • Placenta previa • Abruptio placentae • Uterine • trauma • Bicornuate uterus • Incompetent cervix ( premature dilatation)/surgery
  • 33. • Maternal • • women younger than 16 and older than 35 • Maternal activity • Prior poor birth outcome • Inadvertent early delivery • Preeclampsia • Chronic medical illness • Infection • Drug abuse • • chorioamnionitis • PROM • Polyhydramnios • Iatrogenic/ trauma
  • 34. PRENATAL CONSIDERATIONS • • Should be delivered in a facility with high risk obstetrical service and level 3 NICU • • Prenatal administration of glucocorticoids to the mother even if there is no time for full course • ETHICS- counselling should include discussions regarding survival rate and both short and long term complications
  • 35. Management Before and During Labour • Prewarmed incubator and appropriate equipment for neonatal intensive care should always be kept ready in the labour room or operating theatre.
  • 36. Adequate Resuscitation • Thermoregulation. A polyethylene wrap or bag used immediately after birth prevents heat loss at delivery in very preterm infants. • Respiratory support, availability of pulse oximetry and blended O2 for resuscitation and low saturation protocol. • If the infant is breathing spontaneously and heart rate >100, (CPAP) of 4–6 cm H2O should be initiated to prevent atelectasis. • Transport. As soon as possible, the infant should be transported to the NICU. • In a prewarmed portabe incubator equipped with blended O2 and CPAP availability. • If not the baby must be wiped dry and wrapped in dry linen before transfer.
  • 37. Admission Routine • Ensure thermoneutral temperature for infant. An incubator or radiant warmer is necessary. • Ventilation in NICU is often necessary if ventilated during transfer. However, some infants take longer to adapt to extrauterine life and may not require ventilation especially those with no risk factors and given a full course of antenatal steroids. • For the larger preterm infants above 1250 grams, review the required ventilation to maintain a satisfactory blood gas and consider extubation if the ventilator requirements are low, patient has good tone and good spontaneous respiration.
  • 38. Admission Routine • Maintain SaO₂ between 89-92% for ELBW; 90-94% for the larger preterm • Head circumference (OFC), length measurements, bathing can be omitted. • Quickly and accurately examine and weigh the infant. • Assess the gestational age with Dubowitz or Ballard score when stable. • Monitor temp, HR, RR, BP and SaO₂.
  • 39. Immediate Care for Symptomatic infants • • Investigations are necessary as indicated : ABG, DXT, FBC, Blood culture, CXR (if respiratory signs and symptoms are present) • • Start on 10% dextrose drip. • • Correct hypotension (keep mean arterial pressure (MAP) > gestational age (GA) in wks). Ensure hyperventilation is not present (a cause of hypotension). If the baby has good tone and is active, observe first as the BP may rise after first few hours of life towards a MAP approximating GA in weeks. • • Correct hypovolaemia: Give 10 ml/kg of Normal Saline over 20-30 mins, or packed cells if anaemic. Avoid repeat fluid boluses unless there is volume loss. • • Start inotrope infusion if hypotension persists after volume correction. • • Start antibiotics after taking cultures e.g. Penicillin and Gentamycin • • Start IV Aminophylline or caffeine in premature infants <32-34 weeks. • • Maintain SaO₂ at 89-92% and PaO₂ at 50 –70 mmHg.
  • 40. General Measures for Premature infants • Monitor vitals signs (colour, temperature, apex beat, respiratory rate). Look for signs of respiratory distress (cyanosis, grunting, tachypnoea, nasal flaring, chest recessions, apnoea). In VLBL and ill infants pulse oximetry and blood pressure monitoring are necessary. • Check Blood Sugar . • Keep warm in incubator at thermoneutral temperature for age and birth weight. ELBW should preferably have humidified environment at least for the first 3 days. • Ensure adequate nutrition. • Provide parental counselling and allow free parental access. • Infection control: observe strict hand washing practices.
  • 41. Temperature and humidity control. • Has large skin surface area and minimal energy reserves, a constant neutral thermal environment (environmental temperature that minimizes heat loss without increasing O2 consumption or incurring metabolic stress) is essential. • To maintain minimal evaporative heat loss, it is best if the environmental humidity is 80. • Warm humidification within the incubator is recommended. • Minimize nosocomial infection in humidified environments.
  • 42. Temperature and Humidity They have poor mechanisms for regulation of temperature and depend on environmental support. • 1. Maintain axillary skin temperature of 36.0–36.5°C. • 2. Record skin temperature. • 3. Record the incubator humidity. • 4. Weigh low birthweight infants at least once daily for management of fluids and electrolytes. • 5. Other heat-conserving practices. (knit hats, fetal positioning, and air boost curtains on incubators.) • 6. Accessory items for infant care must be prewarmed. To avoid heat loss by conduction.
  • 43. Infusion fluid volumes Preterm low birthweight infants (>1500 g) require 60–80 mL/kg/d. Preterm very low birthweight infants (1000–1500 g) require 80–100 mL/kg/d. Preterm extremely low birthweight infants (<1000 g) require a range of fluid volumes from 50–80 mL/kg/d if cared for in doublewalled humidified (80%) incubators. If cared for under a radiant warmer or in incubators without humidity, fluid requirements may be 100–200 mL/kg/d (see Table 12–1 for breakdown into 100-g birthweight increments).
  • 44.
  • 45. Nutrition • Breast milk is the milk of choice. All mothers should be encouraged to give breast milk to their newborn babies. • Infant Formula Infant formula should only be given if there is no supply of EBM. • Preterm formula : for babies born < 32 weeks or < 1500 grams • It is recommended to add HMF to EBM as it will give extra calories, vitamins, calcium and phosphate. • Preterm infants : 120 – 140 kcal/kg/day • Babies who have had a more eventful course need up to 180kcal/kg/day to have adequate weight gain. • TPN can be start within the first 24 hours OL in the smaller preterm infants BW <1250 grams or as indicated.
  • 46. Minimal enteral feeding (MEF) • Recommended in very preterm infants • The principle is to commence very low volume enteral feeds on day 1 - 3 of life (i.e. 5 - 25 mls/kg/day) for both EBM and formula milk. • MEF enhances gut DNA synthesis hence promotes gastrointestinal growth. • This approach allows earlier establishment of full enteral feeds and shorter hospital stays, without any concomitant increase in NEC.
  • 47.
  • 48. Vitamins & Iron • At birth: IM Vitamin K (0.5 mg for BW<2.5 kg; 1 mg for BW ≥ 2.5 kg) • MVT can be given after day 14 of life when on feeding of 150 ml/s kg/day.(once on full feeding) • Supplements at 0.5 mls daily to be continued for 3-4 months post discharge. • Premature infants have reduced intra uterine iron accumulation and can become rapidly depleted of iron when active erythropoiesis resumes. Babies of BW< 2000g should receive iron supplements. • Iron is given at a dose of 3 mg/kg elemental iron per day. • Ferric Ammonium Citrate (400mg/5mls) contains 86 mg/5 mls of elemental iron. • Start on day 42 (6 week), continue until 3-4 months post discharge or until review. • Babies who have received multiple blood transfusions may not require as much iron supplementation.
  • 49. Immunisation • Hep B vaccine at birth if infant stable and BW is >1.8 kg. Otherwise give before discharge. • Ensure BCG vaccine is given on discharge. • For long stayers other immunisation should generally follow the schedule according to chronological rather than corrected age. • Defer immunisation in the presence of acute illnesses.
  • 50. Skin care • Zinc-based tape can be used. • Alternatives to tape include the use of a hydrogel adhesive, which removes easily with water. Products also include electrodes, temperature probe covers, and masks. • Skin care must focus on maintaining skin integrity and minimizing exposure to topical agents. • Transparent adhesive dressings can be used over areas of bone prominence, such as the knees or elbows, to prevent skin friction breakdown and under adhesive monitoring devices that are frequently moved. • Use of humidity helps maintain skin integrity until skin is mature (2–3 weeks).
  • 52. Generally Early • Hypothermia – large surface area, thin skin, less fat (less brown fat, more glycogen). • Hypoglycemia • Infection
  • 53. RESPIRATORY ISSUES • Poor development of respiratory muscles- CPAP or ventilator support • a) Perinatal depression-special care air-oxygen mixtures, oximetry monitoring, prevent heat loss • b) RDS- due to surfactant deficiency • • APNEA • Due to developmental immaturity of central respiratory drive
  • 54. RDS • ~91% at 23–25 weeks’ gestation, 88% at 26–27 weeks’, gestation, 74 % at 28–29 weeks’ gestation, and 52% at 30–31 weeks’ gestation. • Sx: Tachypnoea, labored breathing, recessions, nasal flaring, expiratory grunting, +-cyanosis • CXR: Uniform reticulogranular pattern (ground glass appearance) with/out low lung volume and peripheral air bronchogram within the first 24 hours of life. • Mx: Antenatal corticosteroids, tocolytic agent, surfactant replacement, Respiratory support; ETT ventilation, CPAP, SIMV, SEDATION Fluid & nutritional support, Antibx
  • 55. Surfactant synthesis begins at 24–28 weeks’ gestation • The survival from RDS is at >90%. RDS accounts for <6%of all neonatal deaths. • Some literature supports early administration of surfactant during the first 4 hours of life to decrease chronic lung disease. • Recent research supports early CPAP in the delivery room over prophylactic surfactant. • Administration criteria for surfactant include absence of antenatal steroids, increased oxygen demand >30%, and a radiograph consistent with surfactant deficiency.
  • 56.
  • 57. Apnea of prematurity • Pause of breathing > 20secs with brady or desaturation, HR drop 30bpm from baseline • Cause: Physiologic immaturity of respiratory centre, lack of pharyngeal muscle tone and collapsed upper airway -usually present after 1–2 days of life, • Mx: Supportive O2, relieve obstruction (CPAP), aminophylline/caffeine citrate as resp. stimulant, mechanical ventilation.
  • 58. NEUROLOGIC • • Perinatal depression • • ICH- from fragile involuting vessels –Cranium USG at 5-7 days • Neurodevelopmental delay, growth failure, cerebral palsy, mental retardation, epilepsy, blindness and deafness
  • 59. IVH and PVL • IVH (intraventricular hemorrhage) - fragile blood vessels in germinal matrix above caudate nucleus - occurs in < 32wks (within 5 days after birth) • Sx: pallor, shock, hypotonia, apnoea, seizure, hydrocephalus • PVL (Periventricular leucomalacia) - necrosis of white matter at dorsal and lateral • Complications: spastic diplegia, cognitive and intelectual deficit, visual deficit, seizure disorder
  • 60. CARDIOVASCULAR • A) hypotension• hypovolemia • cardiac dysfunction • sepsis induced vasodilation • • B) PDA- between 24-48 hrs of birth
  • 61. Patent Ductus Arteriosus • Incidence of persistent PDA is inversely proportional to gestational age. • SSx include: Wide pulse pressure/ bounding pulses • Systolic or continuous murmur • Tachycardia • Lifting of xiphisternum with heart beat • Hyperactive precordium • Apnoea • Increase in ventilatory requirements • An echocardiogram is recommended to rule out other structural heart defects and confirmation of PDA when concerned. • Overhydration must be avoided. • Up to 30% of PDAs spontaneously close.
  • 62. PDA • Currently it is unclear whether a conservative, pharmacologic or surgical approach is advantageous. • If the decision is made to treat a hemodynamically significant PDA, indomethacin or ibuprofen is generally accepted. • Renal and GI adverse effects are less common with administration of ibuprofen or with slower infusion rates of indomethacin.
  • 63. PDA • IV or oral Indomethacin 0.2mg/kg/day daily dose for 3 days or • IV or oral Ibuprofen 10mg/kg first dose, 5mg/kg second and third doses, administered by syringe pump over 15 minutes at 24 hour intervals. Surgical ligation • Persistence of a symptomatic PDA and failed 2 courses of Indomethacin • If medical treatment fails or contraindicated In older preterm infant who is asymptomatic, i.e. only cardiac murmur present in an otherwise well baby – no treatment required. Most PDA in this group will close spontaneously.
  • 64. HEMATOLOGIC • • A) anaemia- exaggeration of normal physiologic anaemia • TRANSFUSION- low RBC volume, low hematocrit <40% • • B) Hyperbilirubinemia • keep SBR <10 mg/dl • • exchange transfusion if > 12mg/dl
  • 65. GI • Increased risk of NEC, paralytic ileus • Feeding intolerance • • formula feeding is an additional risk factor • • breast milk- protective • gradual increments in feeds • • Renal- immature kidneys-low GFR
  • 66. NEC • Ischemic and inflammatory necrosis of the bowel primarily affecting premature neonates after the initiation of enteral feeding. • Incidence 6–10% in infants weighing <1500 g. • Usually occurs within 1st week of life/ between 14 and 20 days of age or 30–32 weeks’ • Sx: Feeding intolerance, abdominal distension, blood in stool, vomit milkcurd /greenish bile, shiny skin abdomen, absent BS • AXR: distended loops of bowel, Pneumatosis, pneumoperitoneum • Mx: keep NBM, start parenteral feeding (TPN/OGT), antibx for 10-14days regimen should cover pathogens that can cause late-onset sepsis + anaerobic coverage if bowel necrosis or perforation. • Complications: bowel perforation, strictures, malabsorption, parenteral nutrition–associated liver disease
  • 67. Prognosis in Prematurity • Mortality and morbidity are inversely related to gestation and birth weight. • Complications include retinopathy of prematurity, chronic lung disease, neurodevelopmental delay, growth failure, cerebral palsy, mental retardation, epilepsy, blindness and deafness
  • 68. FOLLOW UP CARE • • Respiratory syncytial virus –most important cause of respiratory infection in premature infants Good hand hygiene, avoid passive cigarette smoking exposure • Influenza vaccine- when older than 6 months • • Immunizations-same schedule as term infants with exception of hepatitis B • Medically stable,thriving infants- hep B as early as 30 days of age regardless of gestational age or bw • • Anaemia- supplemental iron(2-3mg/kg) for first 12-15 months of life • Multivitamin drops- 2 weeks of age • • Rickets- higher risk infants- long term parenteral nutrition, frusemide and fat malabsorption • All breast fed infants- 400 IU of vit D along with calcium 200mg/kg at time of discharge • • Metabolic screening at 3-4 weeks of age
  • 69. Screening Cranial Ultrasound for premature infants ≤ 32 weeks is recommended at: • • Within first week of life to look for intraventricular haemorrhage (IVH). • • Around day 28 to look for periventricular leucomalacia (PVL). • • As clinically indicated. Screening for Retinopathy of Prematurity (ROP) at 4-6 weeks of age is recommended for • All infants ≤ 32 weeks gestation at birth or birth weight <1500 g. • All preterms < 36 weeks who received oxygen therapy depending on individual risk as assessed by the clinician. • The infants are discharged once they are well, showing good weight gain, established oral feeding and gestational age of at least 35 weeks.
  • 70. When is infant ready for discharge?? Once they are well, showing good weight gain, established oral feeding and gestational age of at least 35 weeks. • • A sustained pattern of weight gain(15-25 gm) • Competent feeding by breast or pallada without cardiorespiratory compromise • Physiologically mature and stable cardiorespiratory function • • An apnea free period(5-7days) • Nutritional risks assessed and therapy dietary modification • • Hearing evaluation • Fundoscopic examination • Neurodevelopmental and neurobehavioral status assessed and explained to parents • Review of hospital course completed. • • Family and parents: • Determine family’s caregiving and psychosocial readiness • Pre discharge education-safe sleep practices and SIDS prevention. • • Parents should be able to- independently and confidently care for their infant; • provide medications, nutritional supplements and any special medical care; • recognize signs and symptoms of illness and respond appropriately • understand the importance of infection control measures and a smoke-free environment.
  • 71. Thank You November 17th is World Prematurity Day On this day, efforts are made to increase awareness of the health risks associated with preterm birth and how to reduce them.
  • 72. References • PAEDIATRIC PROTOCOLS For Malaysian Hospitals (3rd Edition) by Hussain Imam Hj Muhammad Ismail/ Ng Hoong Phak/Terrence Thomas • NEONATOLOGY Management, Procedures, On-Call Problems, Diseases, and Drugs (7th Edition) by LACY GOMELLA, MD/M. DOUGLAS CUNNINGHAM, MD/FABIEN G. EYAL, MD • https://emedicine.medscape.com/article/prematurity/ updated Oct 13, 2017 by Susan A Furdon, RNC, NNP-BC, MS Neonatal Clinical Nurse Specialist/Nurse Practitioner, Department of Pediatrics, Albany Medical Center

Editor's Notes

  1. “Best estimate” of gestational age, since variability as much as 2 weeks can occur. 1. Maternal history a. Date of last menstrual period. Reliable if dates remembered. The first day of the last menstrual period is about 2 weeks before ovulation and about 3 weeks before blastocyst implantation. b. Assisted reproductive technology. known date of conception and can accurately predict gestational age within 1 day. the gestational age is calculated by adding 2 weeks to the chronological age (time elapsed from birth). Intrauterine insemination may have a few days’ delay. c. Quickening. (18–20 weeks for a primigravida, 15–17 weeks for a multipara).
  2. a. Pelvic examination. Uterine size by bimanual examination in the first trimester can be accurate within 2 weeks. b. Symphysis pubis fundal height. This is accurate up to 28–30 weeks’ gestation. It is only accurate within 4 weeks. One centimeter is equal to 1 week from the 18th to 20th weeks of gestation. At 20 weeks the fundus is at the umbilicus, and at term it is at the xiphoid process.
  3. iii. First trimester examination (a) Gestational sac mean diameter It is accurate within 1 week. (b) Crown-rump length measures the embryo at the tip of the cephalic pole to the tip of the caudal pole and is the most reliable measurement of gestational age. It is used to date pregnancy between 6 and 14 weeks. It is accurate within 5 days. iv. Second- and third-trimester examination. The most common is the biparietal diameter, It determines gestational age with 95% confidence within 7 days if done between 14 and 20 weeks of gestation. Other parameters used are head circumference, abdominal circumference, femur length, fetal foot length, and etc. Measurements in the second trimester are generally accurate within 10–14 days and in the third trimester within 14–21 days
  4. Observe with infant quiet and supine position
  5. Hand flexed on forearm between thumb and index finger of examiner Enough gentle pressure applied to get full flexion as possible Angle btween hypothenar eminence and ventral aspect of forearm measured
  6. Infant in suoine position Forearm first flex for 5sec, then fully extended by pulling of hands and then released Sign fully positive if arms return briskly to full flexion
  7. Infant in supine n pelvis flat on examining couch The thigh held in knee-chest positioned by examiner Left index finger n thumb supporting knee Leg then extended by gentle pressure from examiner Rt index finger behind the ankle And popliteal angle measured
  8. Baby in supine Take infants hand n try to put it around neck and as far posteriorly as possible around opposite shoulder Assist maneuver by lifting the elbow across the body See how far the elbow go acrossed
  9. Baby in supine Draw baby foot as near to head as it will go without forcing it. Observe the distance btween foot and head as well as degree extension of knee Note that knee left free and may draw down alongside abdomen
  10. Pregnancy problem – multiple gestation, poly/oligohydramnios, placenta previa/abruptio, fetal abnormality Risky Behaviour – smoking, substance abuse, poor nutrition Early delivery – Rh Incompatibility, IUGR Medical – Uterine/cervical abnormality, myoma, hypertension
  11. Immunisation: • Hep B vaccine at birth if infant stable and BW is >1.8 kg. Otherwise give before discharge. • Ensure BCG vaccine is given on discharge. • For long stayers other immunisation should generally follow the schedule according to chronological rather than corrected age. • Defer immunisation in the presence of acute illnesses. Supplements: • At birth: IM Vitamin K (0.5 mg for BW<2.5 kg; 1 mg for BW ≥ 2.5 kg) • Once on full feeding, give Infant Multivitamin drops 1 mls OD (continue till fully established weaning diet). For preterm infants, use a formulation with Vit D 400 IU, and Folic acid 1 mg OD. • Starting at about 4 weeks of life: Elemental Iron 2-3 mg/kg/day – to be continued for 3-4 months.
  12. Hypothermia: Skin temperature is <36.0°C Warming. Set the warmer 0.4°C higher than the infant’s temperature. Continue this procedure until the desired temperature is achieved. Do not rewarm faster than 1°C/h. When skin temperature of 36.5°C is achieved, rewarming efforts should be gradually discontinued and temperature maintainence be monitored. Rapid rewarming must be avoided because core body temperatures >37.5°C cause increased insensible water losses, increased O2 consumption, apneic episodes, increased incidence of intraventricular hemorrhage, deviations in vital signs, and a detrimental effect on neurodevelopment. Hyperthermia (skin temperature >37.0°C). Set the warmer temperature control to 0.4°C lower than the infant’s skin temperature. Continue to reduce the warmer temperature until desired temperature is achieved. If increased temperature persists, consider evaluation for pathologic conditions such as sepsis, intraventricular hemorrhage, or mechanical overheating by exterior lamps. Do not turn off the warmer, as this may cause a sudden decrease in the infant’s temperature.
  13. Glucose Best achieved by using D5W or D7.5W infusion fluids to avoid hyperglycemia. Because of the high fluid requirements in the smallest infants, glucose utilization may not be sufficient to prevent buildup of serum glucose and a hyperosmolar state secondary to hyperglycemia. If allowable, reduced glucose maintenance is preferred, but extremes of hyperglycemia (>150 mg/dL)~8mmol/l may require insulin therapy. Sodium During the first week of life, fluid therapy should be managed by increments or decrements of 20–40/mL/kg/d depending on weight changes and serum sodium values, keep serum sodium at 135–140 mEq/L. Sodium supplementation is not usually required in the first 2–3 days of life. Sodium supplementation is begun on the basis of body weight losses. Usually by day 3–5, weight loss and a slight serum sodium decrease from baseline dictate the need to start sodium supplementation by way of the infusion fluids. Judicious restriction of sodium intake during the first 3–5 days of life facilitates a trend for normal serum osmolarity throughout the first week of life for preterm infants. i. During the first 48 hours after birth. prone to increased serum potassium levels of ≥5 mEq/L (range, 4.0–8.0 mEq/L). Most clinicians recommend that no potassium be given during the prediuretic phase. The increase is mostly a result of the following: (a) Relative hypoaldosteronism (b) Shift of intracellular potassium to the extracellular space due to an immature Na+, K+-ATPase pump (c) Immature renal tubular function (d) Lack of arginine, a precursor to insulin ii. K+ >6 mEq/L mandates close ECG monitoring T-wave changes and rhythm disturbances along with electrolyte trends, acid-base status, and urine output. Acidosis should be aggressively treated because this tends to cause intracellular potassium to leak out. Use of Kayexalate enemas is controversial in this age group and best avoided if possible. Albuterol metered-dose inhaler (MDI) (4 puffs every 2 hours; 1 puff = 90 mcg) can reduce high levels. Serum K+ >7 mEq/L can also be treated with insulin, NaHCO3, and calcium gluconate. iii. 3–6 days after birth. Usually by this time, the initially elevated K+ level begins to decrease. When K+ levels approach 4 mEq/L, add supplemental K+ to IV fluids. Begin with 1–2 mEq/kg/d. Measure serum K+ every 6–12 hours until the level is stabilized. Calcium Serum calcium should be monitored daily. Hypocalcemia in preterm infants is a serum calcium <6 mg/dL. Asymptomatic hypocalcemia is not treated with additional calcium because it resolves with time. Symptomatic hypocalcemia is treated with calcium salts. This decrease usually happens on the second day of life.
  14. a. Day 1. During the immediate postnatal period, critically ill premature infants may require volume resuscitation for shock or acidosis. Fluids administered during stabilization should be considered when planning subsequent fluid management. b. Days 1–3. Infusion fluid therapy is aimed at allowing a 10–15% body weight loss through the first week while maintaining TBW balance and electrolyte balance. c. Days 3–7. Infusion fluids should be advanced or decreased as the transition period progresses. Excessive weight loss suggests increased IWL losses and the threat of dehydration. Likewise, edema and minimal or no weight loss suggests excessive fluid administration or decreasing renal function and decreased urine output. • Empirically: - A preterm infant need 4-5 mmol/kg/day of sodium and 2-3 mmol/kg/day of potassium, after the first few days of life. - ELBW infants are prone for hyperkalaemia and adjustments should be made based on serum electrolytes.
  15. (EBM) alone is not adequate for the nutritional needs of the very preterm infant as it: • Has insufficient calories and protein to for optimal early growth at 20 kcal/30mls. • Has insufficient sodium to compensate for high renal sodium losses. • Has insufficient calcium or phosphate - predisposes to osteopenia of prematurity. • Is low in vitamins and iron relative to the needs of a preterm infant. Human Milk Fortifier (HMF) • It is recommended to add HMF to EBM in babies < 32 wks or < 1500 grams. • HMF will give extra calories, vitamins, calcium and phosphate. • HMF should be added to EBM when the baby is feeding at 75 mls/kg/day. • VLBW infants on exclusive breastmilk may require sodium supplementation until 32-34 weeks corrected age. Infant Formula Infant formula should only be given if there is no supply of EBM. There are 2 types of infant formula: Preterm formula and Normal Term Formula. . Minimal enteral feeding (MEF) is recommended in very preterm infants. The principle is to commence very low volume enteral feeds on day 1 - 3 of life (i.e. 5 - 25 mls/kg/day) for both EBM and formula milk. MEF enhances gut DNA synthesis hence promotes gastrointestinal growth. This approach allows earlier establishment of full enteral feeds and shorter hospital stays, without any concomitant increase in NEC Preterm infants • Increase feed accordingly to 180 to 200 mls/kg/day. (This should only be achieved by Day 10 to Day 14 respectively if baby had tolerated feeds well from Day 1) • If on EBM, when volume reaches 75 mls/kg/day: add HMF. Preterm formula meant for newborn preterm infants should not be given to infants > 2 months post conceptual age in view of potential Vitamin A and D toxicity The goal of TPN is to • Provide sufficient nutrients to prevent negative energy and nitrogen balance and essential fatty acid deficiency. • Support normal growth rates without increased significant morbidity. Indication for TPN • Birth weight < 1000 gm • Birth weight 1000-1500 gm and anticipated to be not on significant feeds for 3 or more days. • Birth weight > 1500 gm and anticipated to be not on significant feeds for 5 or more days. • Surgical conditions in neonates: necrotizing enterocolitis, gastroschisis, omphalocoele, tracheo-esophageal fistula, intestinal atresia, malrotation, short bowel syndrome, meconium ileus and diaphragmatic hernia. Goal is to provide 120-130 KCal/kg/day. • 10% dextrose solution provides 0.34 KCal/ml. • 10% lipid solution gives 0.9 KCal/ml; 20% lipid solution gives 1.1 KCal/ml. • Protein/Energy ratio: 3-4 gm/100 KCal is needed to promote protein accretion. A baby given only glucose will lose 1.5 grams body protein/day. Thus it is important to start TPN within the first 24 hours of life in the smaller preterm infants <1250 grams birth weight
  16. Feeding problems • Difficulty in self feeding • In coordination of sucking and swallowing • Abdominal distension • Regurgitation and aspiration
  17. At birth: IM Vitamin K (0.5 mg for BW<2.5 kg; 1 mg for BW ≥ 2.5 kg) • Once on full feeding, give Infant Multivitamin drops 1 mls OD (continue till fully established weaning diet). For preterm infants, use a formulation with Vit D 400 IU, and Folic acid 1 mg OD. • Starting at about 4 weeks of life: Elemental Iron 2-3 mg/kg/day – to be continued for 3-4 months. Medium-Chain Triglycerides (MCT) - A Source of Easily Digested Fat MCT OIL, medium chain triglycerides, is a fat source for those who are unable to digest or absorb conventional fats. MCTs do not require digestive enzymes or bile acids for digestion and absorption. 115 kal in 15 ml…I ounce 28g
  18. Retinopathy of prematurity (ROP). A disorder of the developing retinal vasculature resulting from interruption of normal progression of newly forming retinal vessels. Vasoconstriction and obliteration of the advancing capillary bed are followed in succession by neovascularization extending into the vitreous, retinal edema, retinal hemorrhages, fibrosis, and traction on, and eventual detachment of, the retina. In most cases, the process is reversed before fibrosis occurs. Advanced stages may lead to blindness
  19. A. An arterial oxygen tension (Pao2) <50 mm Hg and central cyanosis in room air B. A characteristic chest radiographic appearance uniform reticulogranular pattern to lung fields with or without low lung volumes and air bronchogram) within the first 24 hours of life. The clinical course of the disease varies with the size of the infant, severity of disease, use of surfactant replacement therapy, presence of infection, degree of shunting of blood through the patent ductus arteriosus (PDA), and whether or not assisted ventilation was initiated. Lack of surfactant. In the absence of surfactant, the small airspaces collapse; each expiration results in progressive atelectasis. Exudative proteinaceous material and epithelial debris, resulting from progressive cellular damage, collect in the airway and directly decrease total lung capacity. In pathologic specimens, this material stains typically as eosinophilic hyaline membranes lining the alveolar spaces and extending into small airways. B. Presence of an overly compliant chest wall. In the presence of a chest wall with weak structural support secondary to prematurity, the large negative pressures generated to open the collapsed airways cause retraction and deformation of the chest wall instead of inflation of the poorly compliant lungs. C. Decreased intrathoracic pressure. The infant with RDS who is <30 weeks’ gestational age often has immediate respiratory failure because of an inability to generate the intrathoracic pressure necessary to inflate the lungs without surfactant. D. Shunting. The presence or absence of a cardiovascular shunt through a PDA or foramen ovale, or both, may change the presentation or course of the disease process. Shortly after birth, the predominant shunting is right to left across the foramen ovale into the left atrium, which may result in venous admixture and worsening hypoxemia. After 18–24 hours, left-to-right shunting through the PDA may become predominant as a result of falling pulmonary vascular resistance, leading to pulmonary edema and impaired alveolar gas exchange. Unfortunately, this usually occurs when the infant is starting to recover from RDS and can be aggravated by surfactant replacement therapy. Blood gas sampling. most neonatologists agree that arterial oxygen tensions of 50–70 mm Hg and arterial carbon dioxide tensions of 45–60 mm Hg are acceptable. Most would maintain the pH at or above 7.25 and the arterial oxygen saturation at 85–93% . Endotracheal intubation and mechanical ventilation: Mainstays of therapy for infants with RDS in whom apnea or hypoxemia with respiratory acidosis develops
  20. Surfactant is a surface-active material produced by airway epithelial cells called type II pneumocytes. This cell line differentiates, and surfactant synthesis begins at 24–28 weeks’ gestation. Type II cells are sensitive to and decreased by asphyxial insults in the perinatal period. The Functions to decrease surface tension and maintain alveolar expansion at physiologic pressures. Depressed preterm infants who have no spontaneous respiration after 30 seconds of ventilation with T-piece resuscitator or resuscitation bag with CPAP attachment and pressure manometers, and thus require positive pressure ventilation (PPV). • Preterm infants below 28 weeks gestation who are given only CPAP from birth in delivery room, i.e. the infant has spontaneous respiration and good tone at birth. Surfactant to be given within 30 minutes after birth. Decision as to whether to leave the patient intubated after surfactant depends on the lung compliance, severity of RDS and degree of prematurity • Preterm infants between 28-32 weeks – to have CPAP from birth in delivery room. To assess requirement for surfactant in NICU based on oxygen requirement of FiO2 > 30% and respiratory distress. To consider INSURE technique – INtubate, SURfactant, Extubate to CPAP • More mature or larger infants should also be given surfactant if the RDS is severe i.e. arterial alveolar (a/A) PO2 ratio of <0.22 or Fraction of inspired (FiO2) > 0.5 Calculation for a/A PO2 ratio : PaO2 (mmHg) (760-47)FiO2 –PaCO2 (mmHg) • To be considered in severe meconium aspiration syndrome with type II respiratory failure – to be used prior to high frequency oscillatory ventilation and nitric oxide to allow the lungs to “open” optimally.
  21. There are two types of surfactant currently available in Malaysia • Survanta , a natural surfactant, bovine derived Dose : 4 ml/kg per dose. • Curosurf , a natural surfactant, porcine derived (not in Blue Book) Dose: 1.25 mls/kg per dose. Method of administration • Insert a 5 Fr feeding tube that has been cut to a suitable length so as not to protrude beyond the tip of the ETT on insertion, through the ETT. If the surfactant is given soon after birth, it will mix with foetal lung fluid and gravity will not be a factor. Therefore no positional changes are required for surfactant given in delivery room. • Surfactant is delivered as a bolus as fast as it can be easily be pushed through the catheter. Usually this takes 2 aliquots over a total of a few minutes. Continue PPV in between doses and wait for recovery before the next aliquot, with adjustments to settings if there is bradycardia or desaturation. Administration over 15 minutes has been shown to have poor surfactant distribution in the lung fields. • Alternatively the surfactant can be delivered through the side port on ETT adaptor without disconnecting the infant from the ventilator. There will be more reflux of surfactant with this method.
  22. Periodic breathing. Periodic breathing is a normal breathing pattern followed by apnea for 5 to 10 seconds without change in heart rate or skin color. Periodic breathing consists of breathing for 10 to 15 seconds followed by apnea for 5 or 10 seconds, without change in heart rate or skin color, and the net effect may be hypoventilation. It is due to an imbalance between the effect of peripheral and central chemoreceptors on ventilatory drive. Periodic breathing in premature infants is often due to excessive stimulation by the chemoreceptors, thus promoting an imbalance. Prevalence of periodic breathing approaches 100% in preterm infants <1000 g. It is more frequent during active sleep. The prognosis is good, and it is controversial whether periodic breathing is associated with an increased risk for apnea of prematurity. Differentiate from Periodic breathing • Regular sequence of respiratory pauses of 10-20 sec interspersed with periods of hyperventilation (4-15 sec) and occurring at least 3x/ minute, not associated with cyanosis or bradycardia. • Benign respiratory pattern for which no treatment is required. • Respiratory pauses appear self-limited, and ventilation continues cyclically. • Periodic breathing typically does not occur in neonates in the first 2 days of life. Methylxanthines increase minute ventilation, improve CO2 sensitivity, decrease hypoxic depression, enhance diaphragmatic activity, and decrease periodic breathing Common side effects include tachycardia, feeding intolerance, emesis, jitteriness, restlessness, and irritability. Toxic effects may produce arrhythmias and seizures. Caffeine has substantially fewer side effects, is better tolerated, and has a high therapeutic index when compared to theophylline.
  23. Intellectual disability is a disability characterized by significant limitations both in intellectual functioning (reasoning, learning, problem solving) and in adaptive behavior, which covers a range of everyday social and practical skills. This disability originates before the age of 18. Spastic diplegia, historically known as Little's Disease, is a form of cerebral palsy (CP) that is a chronic neuromuscular condition of hypertonia and spasticity—manifested as an especially high and constant "tightness" or "stiffness"—in the muscles of the lower extremities of the human body,
  24. Gestational age is the most important determinant of the incidence of patent ductus arteriosus (PDA). The other risk factors for PDA are lack of antenatal steroids, respiratory distress syndrome (RDS) and need for ventilation. Clinical Features • Wide pulse pressure/ bounding pulses • Systolic or continuous murmur • Tachycardia • Lifting of xiphisternum with heart beat • Hyperactive precordium • Apnoea • Increase in ventilatory requirements Complications • Congestive cardiac failure • Intraventricular haemorrhage (IVH) • Pulmonary haemorrhage • Renal impairment • Necrotising enterocolitis • Chronic lung disease
  25. • Indomethacin or ibuprofen is contraindicated if - Infant is proven or suspected to have infection that is untreated. - Bleeding, especially active gastrointestinal or intracranial. - Platelet count < 60 x 109/L - NEC or suspected NEC - Duct dependant congenital heart disease - Impaired renal function: creatinine > 140 µmol/L, blood urea >14 mmol/L. • Monitor urine output and renal function. If urine output < 0.6 ml/kg/hr after a dose given, withhold next dose until output back to normal. • Monitor for GIT complications e.g. gastric bleeding, perforation. Indomethacin can also be considered for IVH prophylaxis, although its safety and benefit remain controversial. Concurrent administration of indomethacin and steroids should be avoided because of the associated risk for spontaneous intestinal perforation.
  26. May involve immature mucosal barrier, mucosal enzymes, and various gastrointestinal (GI) hormones The early clinical presentation may include feeding intolerance, increased gastric residuals, and blood in stools. Specific abdominal signs include abdominal distension, tenderness, abdominal skin discoloration, emesis, and bilious drainage from nasogastric tube. Nonspecific signs include symptoms and signs of neonatal sepsis including increased apnea/bradycardia episodes, temperature instability, hypotension, and circulatory shock. The modified Bell’s staging criteria is often used to classify NEC according to clinical and radiographic presentations. A. Stage I: suspected NEC 1. Systemic signs. Nonspecific, including apnea, bradycardia, lethargy, and temperature instability. 2. Intestinal findings. Feeding intolerance, recurrent gastric residuals, and abdominal distension. 3. Radiographic findings. Normal or nonspecific. B. Stage II: proven NEC 1. Systemic signs. Include Stage I signs plus abdominal tenderness and thrombocytopenia. 2. Intestinal findings. Prominent abdominal distension, tenderness, bowel wall edema, absent bowel sounds, and gross bloody stools. 3. Radiographic findings. Pneumatosis with or without portal venous gas. (gas cyst in bowel wall) C. Stage III: advanced NEC 1. Systemic signs. Respiratory and metabolic acidosis, respiratory failure, hypotension, decreased urine output, shock, neutropenia, and disseminated intravascular coagulation (DIC). 2. Intestinal findings. Tense, discolored abdomen with spreading abdominal wall edema, induration, and discoloration. 3. Radiographic findings. Pneumoperitoneum . Antibiotic therapy. Treat with parenteral antibiotics for 10–14 days. Antibiotic regimen should cover pathogens that can cause late-onset sepsis in premature infants. Add anaerobic coverage if bowel necrosis or perforation is suspected. Reasonable antibiotic regimens include a. Vancomycin, gentamicin, and clindamycin (or metronidazole). b. Vancomycin and piperacillin/tazobactam. c. Vancomycin, gentamicin, and piperacillin/tazobactam (Zosyn). d. Term infants may be treated with ampicillin, gentamicin, and clindamycin. Surgical management. A pneumoperitoneum is an absolute indication for surgical intervention. Relative indications for surgery include portal venous gas, abdominal wall edema and cellulitis (indicating peritonitis), fixed dilated intestinal segment by x-ray (sentinel loop), tender abdominal mass, and clinical deterioration refractory to medical management.
  27. Rickets Clinical presentation. Clinically, osteopenia manifests between 6 and 12 weeks of age and is usually asymptomatic; however, severe manifestations may include the following: A. Severe manifestations 1. Poor weight gain and growth failure. 2. Rickets-like findings may include growth retardation, frontal bossing, craniotabes, prominence of the costochondral junction (rachitic rosary), and epiphyseal widening. 3. Fractures may manifest as pain on handling. 4. Respiratory difficulties or failure to wean off ventilator support due to poor chest wall compliance. B. Consequences of osteopenia. Osteopenia can result in myopia of prematurity due to alterations in the shape of the skull. In childhood, infants remain thinner and shorter with a decreased total BMC and density. Increased urinary calcium excretion has also been reported.